Mimedx (MDXG) Cash from Financing Activities (2011 - 2026)
Mimedx's (MDXG) quarterly Cash from Financing Activities came in at -$13.3 million in Q2 2026, down 1114.26% year-over-year from $1.3 million in Q2 2025, and down 413.89% quarter-over-quarter from -$2.6 million in Q1 2026.
Powered by 
Analysis
Mimedx (MDXG) Cash from Financing Activities (2011 - 2026) Analysis & Trends
Mimedx has disclosed Cash from Financing Activities across 16 years of filings, most recently posting -$13.3 million for Q2 2026.
- In Q2 2026, Cash from Financing Activities fell 1114.26% year-over-year to -$13.3 million; the TTM figure through Jun 2026 stood at -$17.3 million (down 298.37% YoY), while the FY2025 annual figure was -$5.4 million, up 84.17% from the prior year.
- Cash from Financing Activities came in at -$13.3 million for Q2 2026 at Mimedx, down from -$2.6 million in the prior quarter.
- In the past five years, Cash from Financing Activities ranged from a high of $370000.0 in Q3 2023 to a low of -$33.5 million in Q1 2024.
- Average Cash from Financing Activities over 5 years is -$3.6 million, with a median of -$491500.0 recorded in 2024.
- Year-over-year, Cash from Financing Activities soared 200.0% in 2022 and slumped 836575.0% in 2024.
- Over 5 years, Cash from Financing Activities stood at $66000.0 in 2022, then slumped by 13645.45% to -$8.9 million in 2023, then surged by 95.53% to -$400000.0 in 2024, then sank by 45.75% to -$583000.0 in 2025, then tumbled by 2178.56% to -$13.3 million in 2026.
- Per Business Quant data, the three most recent Cash from Financing Activities figures were -$13.3 million in Q2 2026, -$2.6 million in Q1 2026, and -$583000.0 in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 180.74 Bn | 175.14 Bn | 7.27 Bn | -3.52 Bn |
| 2 | Intuitive Surgical | 127.56 Bn | 122.34 Bn | 1.96 Bn | -287.90 Mn |
| 3 | Medtronic | 116.90 Bn | 108.08 Bn | 6.34 Bn | -343.00 Mn |
| 4 | Stryker | 103.85 Bn | 100.37 Bn | 4.50 Bn | -95.00 Mn |
| 5 | Boston Scientific | 63.70 Bn | 63.16 Bn | 3.85 Bn | -410.00 Mn |
| 6 | Edwards Lifesciences | 49.88 Bn | 45.63 Bn | 1.35 Bn | -300,000.00 |
| 7 | Alcon | 33.04 Bn | 31.59 Bn | 1.68 Bn | -510.00 Mn |
| 8 | Dexcom | 32.18 Bn | 30.23 Bn | 830.00 Mn | -607.30 Mn |
| 9 | Steris | 20.65 Bn | 20.17 Bn | 684.20 Mn | -213.50 Mn |
| 10 | Mimedx | 670.99 Mn | 535.15 Mn | 44.38 Mn | -13.28 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -13.28 Mn |
| Mar 31, 2026 | -2.59 Mn |
| Dec 31, 2025 | -583,000.00 |
| Sep 30, 2025 | -857,000.00 |
| Jun 30, 2025 | -1.09 Mn |
| Mar 31, 2025 | -2.88 Mn |
| Dec 31, 2024 | -400,000.00 |
| Sep 30, 2024 | 27,000.00 |
| Jun 30, 2024 | -359,000.00 |
| Mar 31, 2024 | -33.47 Mn |
| Dec 31, 2023 | -8.94 Mn |
| Sep 30, 2023 | 370,000.00 |
| Jun 30, 2023 | 4,000.00 |
| Mar 31, 2023 | -4,000.00 |
| Dec 31, 2022 | 66,000.00 |
| Sep 30, 2022 | 130,000.00 |
| Jun 30, 2022 | 260,000.00 |
| Mar 31, 2022 | -1.04 Mn |
| Dec 31, 2021 | 22,000.00 |
| Sep 30, 2021 | -150,000.00 |